SCICLONE PHARMACEUTICALS INC
S-8, EX-23.2, 2000-09-14
PHARMACEUTICAL PREPARATIONS
Previous: SCICLONE PHARMACEUTICALS INC, S-8, EX-5, 2000-09-14
Next: AMYLIN PHARMACEUTICALS INC, SC 13D/A, 2000-09-14



<PAGE>   1

                                                                    EXHIBIT 23.2

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS



We consent to the incorporation by reference in the Registration Statement (Form
S-8) pertaining to the 1995 Equity Incentive Plan and the 1995 Nonemployee
Director Stock Option Plan of SciClone Pharmaceuticals, Inc., of our report
dated January 28, 2000, with respect to the consolidated financial statements
and schedule of SciClone Pharmaceuticals, Inc., included in its Annual Report on
Form 10-K/A for the year ended December 31, 1999 filed with the Securities and
Exchange Commission.



                                                           /s/ ERNST & YOUNG LLP

Palo Alto, California
September 12, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission